The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

European Journal of Internal Medicine - Tập 76 - Trang 14-20 - 2020
Paolo Verdecchia1, Claudio Cavallini1, Antonio Spanevello2,3, Fabio Angeli2,3
1Fondazione Umbra Cuore e Ipertensione-ONLUS and Struttura Complessa di Cardiologia, Ospedale S. Maria della Misericordia, Perugia.
2Dipartimento di Medicina e Chirurgia, Università degli Studi dell'Insubria, Varese
3Dipartimento di Medicina e Riabilitazione Cardio-Respiratoria, Istituti Clinici Scientici Maugeri, IRCCS Tradate (VA)

Tóm tắt

Từ khóa


Tài liệu tham khảo

Chan-Yeung, 2003, SARS: epidemiology, Respirology, 8

Hoffmann, 2020, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, 10.1016/j.cell.2020.02.052

Walls, 2020, Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein, Cell, 10.1016/j.cell.2020.02.058

Tipnis, 2000, A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase, J Biol Chem, 275, 33238, 10.1074/jbc.M002615200

Donoghue, 2000, A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9, Circ Res, 87, E1, 10.1161/01.RES.87.5.e1

Vickers, 2002, Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase, J Biol Chem, 277, 14838, 10.1074/jbc.M200581200

Li, 2003, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, 426, 450, 10.1038/nature02145

Xu, 2020, Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission, Sci China Life Sci, 63, 457, 10.1007/s11427-020-1637-5

Hussain, 2020, Structural Variations in Human ACE2 may Influence its Binding with SARS-CoV-2 Spike Protein, J Med Virol, 10.1002/jmv.25832

Glowacka, 2011, Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response, J Virol, 85, 4122, 10.1128/JVI.02232-10

Crackower, 2002, Angiotensin-converting enzyme 2 is an essential regulator of heart function, Nature, 417, 822, 10.1038/nature00786

Batlle, 2020, Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?, Clin Sci (Lond), 134, 543, 10.1042/CS20200163

Kuba, 2013, Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases, Circ J, 77, 301, 10.1253/circj.CJ-12-1544

Patel, 2016, Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure, Circ Res, 118, 1313, 10.1161/CIRCRESAHA.116.307708

Turner, 2004, ACE2: from vasopeptidase to SARS virus receptor, Trends Pharmacol Sci, 25, 291, 10.1016/j.tips.2004.04.001

Zhang, 2020, Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target, Intensive Care Med, 10.1007/s00134-020-05985-9

Xu, 2017, Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension, Circ Res, 121, 43, 10.1161/CIRCRESAHA.116.310509

Bitker, 2019, Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill, Crit Care Clin, 35, 213, 10.1016/j.ccc.2018.11.002

Wysocki, 2017, Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease, Am J Physiol Renal Physiol, 313, F487, 10.1152/ajprenal.00074.2017

Yang, 2007, Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection, Comp Med, 57, 450

Huentelman, 2004, Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor, Hypertension, 44, 903, 10.1161/01.HYP.0000146120.29648.36

Kuba, 2005, A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury, Nat Med, 11, 875, 10.1038/nm1267

Trask, 2007, Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats, Am J Physiol Heart Circ Physiol, 292, H3019, 10.1152/ajpheart.01198.2006

Bernstein, 2018, Angiotensin-converting enzyme in innate and adaptive immunity, Nat Rev Nephrol, 14, 325, 10.1038/nrneph.2018.15

Recinos, 2007, Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice, Atherosclerosis, 194, 125, 10.1016/j.atherosclerosis.2006.10.013

Yamamoto, 2011, Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis, Arterioscler Thromb Vasc Biol, 31, 2856, 10.1161/ATVBAHA.111.237198

Lee, 2002, Cytokines, chemokines, and cytokine receptors in human microglia, J Neurosci Res, 69, 94, 10.1002/jnr.10253

Santos, 2018, The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7), Physiol Rev, 98, 505, 10.1152/physrev.00023.2016

Magalhaes, 2015, Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation, Br J Pharmacol, 172, 2330, 10.1111/bph.13057

El-Hashim, 2012, Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-kappaB-dependent pathways, Br J Pharmacol, 166, 1964, 10.1111/j.1476-5381.2012.01905.x

Chen, 2013, Angiotensin-(1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury, J Surg Res, 185, 740, 10.1016/j.jss.2013.06.052

Li, 2015, Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-kappaB pathways, Sci Rep, 5, 8209, 10.1038/srep08209

Meng, 2014, Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-kappaB pathway, Am J Respir Cell Mol Biol, 50, 723, 10.1165/rcmb.2012-0451OC

Sodhi, 2018, Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg(9) bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration, Am J Physiol Lung Cell Mol Physiol, 314, L17, 10.1152/ajplung.00498.2016

Fang, 2013, Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation, Blood, 121, 3023, 10.1182/blood-2012-09-459156

Fraga-Silva, 2008, The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets, Mol Med, 14, 28, 10.2119/2007-00073.Fraga-Silva

Kucharewicz, 2002, Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7), Hypertension, 40, 774, 10.1161/01.HYP.0000035396.27909.40

Pai, 2017, Angiotensin-(1-7) Inhibits Thrombin-Induced Endothelial Phenotypic Changes and Reactive Oxygen Species Production via NADPH Oxidase 5 Downregulation, Front Physiol, 8, 994, 10.3389/fphys.2017.00994

Fraga-Silva, 2011, An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect, Clinics (Sao Paulo), 66, 837, 10.1590/S1807-59322011000500021

Liang, 2015, Angiotensin-(1-7) Attenuates Angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-kappaB Pathways in HUVECs, Cell Physiol Biochem, 35, 2472, 10.1159/000374047

Mehta, 2007, Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system, Am J Physiol Cell Physiol, 292, C82, 10.1152/ajpcell.00287.2006

Yuan, 2013, Ang(1-7) treatment attenuates beta-cell dysfunction by improving pancreatic microcirculation in a rat model of Type 2 diabetes, J Endocrinol Invest, 36, 931

Gembardt, 2005, Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents, Peptides, 26, 1270, 10.1016/j.peptides.2005.01.009

Gupte, 2008, ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet, Am J Physiol Regul Integr Comp Physiol, 295, R781, 10.1152/ajpregu.00183.2008

Gupte, 2012, Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice, Arterioscler Thromb Vasc Biol, 32, 1392, 10.1161/ATVBAHA.112.248559

Patel, 2016, ACE2/Ang 1-7 axis: A critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity, Adipocyte, 5, 306, 10.1080/21623945.2015.1131881

Patel, 2016, ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity, Diabetes, 65, 85, 10.2337/db15-0399

Imai, 2005, Angiotensin-converting enzyme 2 protects from severe acute lung failure, Nature, 436, 112, 10.1038/nature03712

Hung, 2016, Alternative Roles of STAT3 and MAPK Signaling Pathways in the MMPs Activation and Progression of Lung Injury Induced by Cigarette Smoke Exposure in ACE2 Knockout Mice, Int J Biol Sci, 12, 454, 10.7150/ijbs.13379

Lin, 2018, Instillation of particulate matter 2.5 induced acute lung injury and attenuated the injury recovery in ACE2 knockout mice, Int J Biol Sci, 14, 253, 10.7150/ijbs.23489

Hamming, 2004, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J Pathol, 203, 631, 10.1002/path.1570

Barkauskas, 2013, Type 2 alveolar cells are stem cells in adult lung, J Clin Invest, 123, 3025, 10.1172/JCI68782

Rivellese, 2020, ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia, Autoimmun Rev, 10.1016/j.autrev.2020.102536

Grasselli, 2020, Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy, JAMA, 10.1001/jama.2020.5394

Wu, 2020, Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China, JAMA Intern Med, 10.1001/jamainternmed.2020.0994

Yang, 2020, Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis, Int J Infect Dis, 10.1016/j.ijid.2020.03.017

Booth, 2003, Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area, JAMA, 289, 2801, 10.1001/jama.289.21.JOC30885

Chan, 2003, Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS), Thorax, 58, 686, 10.1136/thorax.58.8.686

Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J Thromb Haemost, 18, 844, 10.1111/jth.14768

Xie, 2006, Age- and gender-related difference of ACE2 expression in rat lung, Life Sci, 78, 2166, 10.1016/j.lfs.2005.09.038

Pal, 2020, COVID-19, Diabetes Mellitus and ACE2: The conundrum, Diabetes Res Clin Pract, 10.1016/j.diabres.2020.108132

Tikellis, 2012, Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease, Int J Pept, 2012, 10.1155/2012/256294

Yamagata, 2020, Downregulation of spinal angiotensin converting enzyme 2 is involved in neuropathic pain associated with type 2 diabetes mellitus in mice, Biochem Pharmacol, 174, 10.1016/j.bcp.2020.113825

Patel, 2014, From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension, Front Physiol, 5, 227, 10.3389/fphys.2014.00227

Wysocki, 2010, Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension, Hypertension, 55, 90, 10.1161/HYPERTENSIONAHA.109.138420

Zhong, 2010, Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction, Circulation, 122, 717, 10.1161/CIRCULATIONAHA.110.955369

Kassiri, 2009, Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction, Circ Heart Fail, 2, 446, 10.1161/CIRCHEARTFAILURE.108.840124

Wang, 2014, Heterozygote loss of ACE2 is sufficient to increase the susceptibility to heart disease, J Mol Med (Berl), 92, 847, 10.1007/s00109-014-1149-y

Mehta, 2020, COVID-19: consider cytokine storm syndromes and immunosuppression, The Lancet, 395, 1, 10.1016/S0140-6736(20)30628-0

Akhmerov, 2020, COVID-19 and the Heart, Circ Res, 10.1161/CIRCRESAHA.120.317055

Peiro, 2020, Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARSCoV2 Infection?, Circulation, 10.1161/CIRCULATIONAHA.120.047297

Ferrario, 2005, Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2, Circulation, 111, 2605, 10.1161/CIRCULATIONAHA.104.510461

Gallagher, 2008, MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides, Am J Physiol Cell Physiol, 295, C1169, 10.1152/ajpcell.00145.2008

Ishiyama, 2004, Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors, Hypertension, 43, 970, 10.1161/01.HYP.0000124667.34652.1a

Jessup, 2006, Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats, Am J Physiol Heart Circ Physiol, 291, H2166, 10.1152/ajpheart.00061.2006

Bavishi, 2020, Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers, JAMA Cardiol, 10.1001/jamacardio.2020.1282

Danser, 2020, Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers, Hypertension, 10.1161/HYPERTENSIONAHA.120.15082

Esler, 2020, Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?, J. Hypertens., 38, 1, 10.1097/HJH.0000000000002450

Fang, 2020, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med, 10.1016/S2213-2600(20)30116-8

Gurwitz, 2020, Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics, Drug Dev Res, 10.1002/ddr.21656

Kuster, 2020, SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?, Eur Heart J, 10.1093/eurheartj/ehaa235

Vaduganathan, 2020, Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19, N Engl J Med, 10.1056/NEJMsr2005760

Verdecchia, 2020, Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus, J Hypertens, 38, 10.1097/HJH.0000000000002469

Verdecchia, 2020, ACE-inibitori, sartani e sindrome respiratoria acuta da coronavirus 2, G Ital Cardiol (Rome), 21, 1